Unlike in the general population, women with stage 5 chronic kidney disease (CKD) do not have a sex-based survival advantage ...

FDA approves pembrolizumab and enfortumab vedotin for neoadjuvant and adjuvant treatment of cisplatin-ineligible muscle-invasive bladder cancer.

Inflation-adjusted annual cost of U.S. medical school attendance increased from $51,400 to $71,000 between 2008 and 2020.

Having a longer travel time to their treatment facility improves survival in prostate cancer patients, according to a recent study.

Researchers explored the relationship between positive mental health literacy, job crafting, and job well-being in palliative care nurses. Job crafting mediates the relationship between positive ...

Authors say widely available foods like tea, coffee, berries, olive oil, nuts, and whole grains may be a practical way to improve long-term cardiovascular disease risk.

Both T1D and T2D independently associated with SCD, with the greatest risk difference seen for younger individuals.

(HealthDay News) — One dose of bivalent or nonavalent human papillomavirus (HPV) vaccine is noninferior to two doses for protecting against HPV16 and HPV18 infection, according to a study published ...

(HealthDay News) — The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight loss as an adjunct to lifestyle modification versus placebo for ...

In this cross-sectional analysis, researchers aimed to characterize the NIH trials affected by grant terminations under the Trump administration. More than 74,000 individuals were enrolled in active ...